China Jo-Jo Drugstores, Inc. (CJJD)
NASDAQ: CJJD · Real-Time Price · USD
1.660
-0.070 (-4.05%)
Dec 20, 2024, 4:00 PM EST - Market closed
China Jo-Jo Drugstores Revenue
In the fiscal year ending March 31, 2024, China Jo-Jo Drugstores had annual revenue of $154.54M with 3.85% growth. China Jo-Jo Drugstores had revenue of $75.97M in the half year ending March 31, 2024, a decrease of -11.57%.
Revenue (ttm)
$154.54M
Revenue Growth
+3.85%
P/S Ratio
0.02
Revenue / Employee
$154,079
Employees
1,003
Market Cap
10.26M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2024 | 154.54M | 5.73M | 3.85% |
| Mar 31, 2023 | 148.81M | -15.58M | -9.48% |
| Mar 31, 2022 | 164.39M | 31.26M | 23.48% |
| Mar 31, 2021 | 133.13M | 15.81M | 13.47% |
| Mar 31, 2020 | 117.33M | 9.78M | 9.09% |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
| Mar 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Zhongchao | 17.41M |
| Kiora Pharmaceuticals | 16.02M |
| Mobile-health Network Solutions | 13.97M |
| Evoke Pharma | 8.62M |
| Ensysce Biosciences | 4.42M |
| Apollomics | 2.10M |
| Can-Fite BioPharma | 667.00K |
| BioRestorative Therapies | 377.00K |
CJJD News
- 5 months ago - China Jo-Jo Drugstores Reports Fiscal Year 2024 Financial Results - PRNewsWire
- 6 months ago - China Jo-Jo Drugstores Announces $3.37 Million Registered Direct Offering - PRNewsWire
- 7 months ago - China Jo-Jo Drugstores Announces Changes to Board of Directors - PRNewsWire
- 8 months ago - China Jo-Jo Drugstores Announces $2.74 Million Registered Direct Offering - PRNewsWire
- 8 months ago - China Jo-Jo Drugstores Announces $1.53 Million Registered Direct Offering - PRNewsWire
- 9 months ago - China Jo-Jo Drugstores Regains Compliance with Nasdaq Minimum Bid Price Requirement - PRNewsWire
- 10 months ago - China Jo-Jo Drugstores, Inc. Announces 1-for-20 Reverse Stock Split - PRNewsWire
- 1 year ago - China Jo-Jo Drugstores Granted A Second Extension to Meet Nasdaq Minimum Bid Price Requirement - PRNewsWire